成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 541-15-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 541-15-1
Chemical Structure| 541-15-1
Structure of 541-15-1 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 541-15-1 ]

Related Doc. of [ 541-15-1 ]

Alternatived Products of [ 541-15-1 ]
Product Citations

Product Citations

Huguenard, Claire J. C. ; Cseresznye, Adam ; Darcey, Teresa , et al. DOI: PubMed ID:

Abstract: With age the apolipoprotein E (APOE) E4 allele (involved in lipid homeostasis) is associated with perturbation of bioenergetics pathways in Alzheimer's disease (AD). We therefore hypothesized that in aging mice APOE genotype would affect the L-carnitine system (central to lipid bioenergetics), in the brain and in the periphery. Using liquid chromatog.-mass spectrometry, levels of L-carnitine and associated metabolites: γ-butyrobetaine (GBB), crotonobetaine, as well as acylcarnitines, were evaluated at 10-, 25-, and 50-wk, in the brain and the periphery, in a targeted replacement mouse model of human APOE (APOE-TR). Aged APOE-TR mice were also orally administered 125 mg/kg of L-carnitine daily for 7 days followed by evaluation of brain, liver, and plasma L-carnitine system metabolites. Compared to E4-TR, an age-dependent increase among E2- and E3-TR mice was detected for medium- and long-chain acylcarnitines (MCA and LCA, resp.) within the cerebrovasculature and brain parenchyma. While following L-carnitine oral challenge, E4-TR mice had higher increases in the L-carnitine metabolites, GBB and crotonobetaine in the brain and a reduction of plasma to brain total acylcarnitine ratios compared to other genotypes. These studies suggest that with aging, the presence of the E4 allele may contribute to alterations in the L-carnitine bioenergetic system and to the generation of L-carnitine metabolites that could have detrimental effects on the vascular system. Collectively the E4 allele and aging may therefore contribute to AD pathogenesis through aging-related lipid bioenergetics as well as cerebrovascular dysfunctions.

Keywords: apolipoproteins ; fatty acid metabolism ; lipid oxidation ; vascular biology ; Alzheimer's disease

Purchased from AmBeed:

Product Details of [ 541-15-1 ]

CAS No. :541-15-1 MDL No. :MFCD00038747
Formula : C7H15NO3 Boiling Point : -
Linear Structure Formula :(CH3)3NCH2CH(OH)CH2COO InChI Key :PHIQHXFUZVPYII-ZCFIWIBFSA-N
M.W : 161.20 Pubchem ID :10917
Synonyms :
(R)-Carnitine;Levocarnitine;Carnitine;ST-198;L-Cartin;Carnitor;R-Carnitine;(–)-Carnitine
Chemical Name :(R)-3-Hydroxy-4-(trimethylammonio)butanoate

Calculated chemistry of [ 541-15-1 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.86
Num. rotatable bonds : 4
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 39.13
TPSA : 60.36 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.88 cm/s

Lipophilicity

Log Po/w (iLOGP) : -2.37
Log Po/w (XLOGP3) : -0.84
Log Po/w (WLOGP) : -1.81
Log Po/w (MLOGP) : -3.79
Log Po/w (SILICOS-IT) : -0.8
Consensus Log Po/w : -1.92

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.05
Solubility : 145.0 mg/ml ; 0.899 mol/l
Class : Very soluble
Log S (Ali) : 0.05
Solubility : 182.0 mg/ml ; 1.13 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -0.74
Solubility : 29.1 mg/ml ; 0.18 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.94

Safety of [ 541-15-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 541-15-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 541-15-1 ]
  • Downstream synthetic route of [ 541-15-1 ]

[ 541-15-1 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 541-15-1 ]
  • [ 6645-46-1 ]
Reference: [1] Patent: WO2017/195031, 2017, A1, . Location in patent: Page/Page column 12; 13
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;